Bo S. Qiu
Meizhou, 514031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 132 publications
Integrating machine learning and deep learning with multiple molecular fingerprints for topoisomerase I inhibitor screening and lead identification.
Journal: Molecular diversity
Published: May 30, 2026
Design, Synthesis and Biological Evaluation of 6H-Benzimidazo[1',2':1,2]pyrido[3,4-b]indole Derivatives as TDP1 Inhibitors: Potent Synergistic Agents with Topotecan against Cervical Cancer.
Journal: Journal of medicinal chemistry
Published: April 21, 2026
Prediction of NOx emissions from co-disposal of municipal solid waste and sludge using a GA-LSTM neural network.
Journal: Environmental technology
Published: May 26, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 25, 2025
Efficacy and safety of combining bevacizumab and fractionated stereotactic radiotherapy for extensive brain metastases in patients with non-small cell lung cancer: a prospective phase II study (GASTO-1053).
Journal: Cancer communications (London, England)
Published: April 14, 2025
Early Nutritional Intervention in Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: A Phase II Prospective Study.
Journal: Nutrients
Published: March 25, 2025
A preliminary analysis of integrating thymosin α1 into concurrent chemoradiotherapy and consolidative immunotherapy in unresectable locally advanced non-small cell lung cancer.
Journal: Translational lung cancer research
Published: February 22, 2025
Abbreviated dynamic total-body [18F]FDG PET/CT protocols for predicting response in locally advanced non-small cell lung cancer via Patlak-Ki analysis.
Journal: Quantitative imaging in medicine and surgery
Published: February 11, 2025
Efficacy and safety of online adaptive magnetic resonance-guided fractionated stereotactic radiotherapy for brain metastases in non-small cell lung cancer (GASTO-1075): a single-arm, phase 2 trial.
Journal: EClinicalMedicine
Published: January 14, 2025
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial.
Journal: Signal transduction and targeted therapy
Published: November 25, 2024
Last Updated: 09/26/2026